Improvement in the utilization of intravenous infusion in inpatients by PDCA cycle method

SHI Yinping; LI Xiao; CUI Xueyan; HUANG Xin; SHI Haiyan; YANG Yilei; HAN Yi; MU Yan; LI Yan

doi:10.6039/j.issn.1001-0408.2022.22.22

您当前的位置：

首页 >

文章列表页 >

Improvement in the utilization of intravenous infusion in inpatients by PDCA cycle method

更新时间：2023-02-22

- Improvement in the utilization of intravenous infusion in inpatients by PDCA cycle method
- ZHONGGUO YAOFANG Vol. 33, Issue 22, Pages: 2797-2800(2022)
- 作者机构：
  
  山东第一医科大学第一附属医院（山东省千佛山医院）临床药学科/山东省儿童药物临床评价与研发工程技术研究中心/山东省医药卫生临床药学重点实验室，济南　250014
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2022.22.22
  CLC： R969.3
- Published：30 November 2022，
  
  Received：21 June 2022，
  
  Revised：30 September 2022，
扫描看全文
时银萍,李晓,崔学艳等.运用PDCA循环法改善住院患者静脉输液使用情况 ^Δ[J].中国药房,2022,33(22):2797-2800.

SHI Yinping,LI Xiao,CUI Xueyan,et al.Improvement in the utilization of intravenous infusion in inpatients by PDCA cycle method[J].ZHONGGUO YAOFANG,2022,33(22):2797-2800.
时银萍,李晓,崔学艳等.运用PDCA循环法改善住院患者静脉输液使用情况 ^Δ[J].中国药房,2022,33(22):2797-2800. DOI： 10.6039/j.issn.1001-0408.2022.22.22.

SHI Yinping,LI Xiao,CUI Xueyan,et al.Improvement in the utilization of intravenous infusion in inpatients by PDCA cycle method[J].ZHONGGUO YAOFANG,2022,33(22):2797-2800. DOI： 10.6039/j.issn.1001-0408.2022.22.22.

摘要

目的

改善住院患者的静脉输液使用情况，提高合理用药水平。

方法

采用PDCA循环法，从制度层面、系统层面、人员层面、管理层面制定对策并实施，以住院患者静脉输液使用率与平均每床日使用袋（瓶）数为指标评价PDCA循环实施的效果。

结果

我院住院患者的静脉输液使用率由PDCA循环实施前3个月的（92.58±0.11）%降至PDCA循环实施结束后3个月的（89.72±0.62）%，静脉输液平均每床日使用袋（瓶）数由5.20±0.09降至4.64±0.24（

＜0.05）；静脉输液使用率由PDCA循环实施前6个月的92.55%降至PDCA循环实施结束后6个月的89.98%（

＜0.05），虽然静脉输液平均每床日使用袋（瓶）数由PDCA循环实施前6个月的5.36±0.26降至PDCA循环实施结束后6个月的4.97±0.39，但差异无统计学意义（

＞0.05）。

结论

PDCA循环法能有效降低住院患者的静脉输液使用率和平均每床日使用袋（瓶）数，提高合理用药水平。

Abstract

OBJECTIVE

To improve the utilization rate of intravenous infusion in inpatients and enhance the level of rational drug use.

METHODS

PDCA cycle method was used to formulate and implement countermeasures from the aspects of institution， system， person and management. The utilization rate of intravenous infusion and the average daily number of bags （bottles） per bed for intravenous infusion were used as indicators to evaluate the implementation effect of PDCA.

RESULTS

The utilization rate of intravenous infusion decreased from （92.58±0.11）% 3 months before PDCA cycle to （89.72±0.62）% 3 months after PDCA cycle， and the average daily number of bags （bottles） per bed from intravenous infusion decreased from 5.20±0.09 to 4.64±0.24 （

＜0.05）. The utilization rate of intravenous infusion decreased from 92.55% 6 months before PDCA cycle to 89.98% 6 months after PDCA cycle （

＜0.05）； but average daily number of bags （bottles） per bed for intravenous infusion decreased from 5.36±0.26 6 months before PDCA cycle to 4.97±0.39 6 months after PDCA cycle， without statistical significance （

＞0.05）.

CONCLUSIONS

PDCA cycle method can effectively reduce the utilization rate and average daily number of bags （bottles） per bed for intravenous infusion in the inpatients and improve the level of rational drug use.

关键词

PDCA循环法住院患者静脉输液合理用药

Keywords

inpatientintravenous infusionrational drug use

references

朱斌，赵志刚. 守护针尖上的安全：中国输液安全与防护专家共识[J]. 药品评价，2016，13（10）：8-17.

国家卫生健康委医政医管局.国家卫生健康委办公厅关于印发2021年国家医疗质量安全改进目标的通知[EB/OL]. [2022-03-30]. http：//www.nhc.gov.cn/yzygj/s7657/202102/8c53313-663284a7ba146648509538ee2.shtmlhttp://www.nhc.gov.cn/yzygj/s7657/202102/8c53313-663284a7ba146648509538ee2.shtml.

国家药品监督管理局.国家药品不良反应监测年度报告[EB/OL]. [2022-03-30]. https：//www.nmpa.gov.cn/xxgk/yjjsh/ypblfytb/20220329161925106.htmlhttps://www.nmpa.gov.cn/xxgk/yjjsh/ypblfytb/20220329161925106.html.

刘佳佳，李志金. PDCA循环在控制药品费用中的应用[J]. 临床合理用药杂志，2021，14（11）：38-41.

梁颖娥，钟慧，蓝晓步，等. 基于循证药学及PDCA循环建立的重点监控药品合理使用评价模式的应用价值[J]. 临床合理用药杂志，2021，14（14）：1-3，6.

龚志成. 先行先试打造降低输液率管理的“湘雅样本”[J]. 中国医院院长，2021，17（9）：82-84.

王辉，谢欣苇，刘正跃，等. 156所综合性医院住院患者静脉输液指标的综合分析[J]. 药学实践杂志，2017，35（6）：573-576.

国家卫生健康委办公厅，国家中医药局办公室. 关于印发第一批国家重点监控合理用药药品目录（化药及生物制品）的通知[EB/OL]. [2022-03-30]. http：//www.nhc.gov.cn/yzygj/s7659/201907/d356ce8a4ba1461ca66c544724dffc-5e.shtmlhttp://www.nhc.gov.cn/yzygj/s7659/201907/d356ce8a4ba1461ca66c544724dffc-5e.shtml.

JOINT COMMISSION INTERNATIONAL. Joint commission international accreditation standards for hospitals [M].5th ed. Chicago：Joint Commission Resources，2014：119-132.

陈宏，方庆全，陈丰庆. JCI理念指导下改善综合性医院ST医嘱执行情况的研究[J]. 中国现代应用药学，2018，35（5）：746-749.

武星，汪滢，薛函. 静脉输液类药物不合理医嘱点评情况分析[J]. 临床合理用药杂志，2016，9（7）：102-103.

王巧玲，马箫. 静脉输液类药物不合理医嘱点评情况分析及合理用药[J]. 医学食疗与健康，2021，19（9）：46-47，49.

王素琴，蒋锦玉. 药学干预在提升静脉输液使用合理率中的应用[J]. 中国继续医学教育，2020，12（21）：143-145.

邓小菊. 静脉输液的认识误区[J]. 保健文汇，2020（5）：133.

李莉，胡媛媛，梁颖红. 药学干预在合理使用中药注射剂方面的作用分析[J]. 中国医药指南，2017，15（28）：175-176.

蔡江霞，叶银梅，杜宪，等. 药学干预对基层三级甲等医院住院患者静脉输液的影响[J]. 中国医院用药评价与分析，2018，18（8）：1126-1128.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Application and evaluation of management mode for the use of antimicrobial drugs in county-level medical communities led by anti-infective clinical pharmacists

Expert consensus on comprehensive clinical evaluation of antidepressant drugs

Effect of posaconazole combined with proton pump inhibitors on blood concentrations and invasive fungal infection in patients with malignant hematological disorders

Clinical comprehensive evaluation of Chinese patent medicine for the treatment of chronic hepatitis B

Comparison of two analysis methods of opioid consumption sum in medical institutions

Related Author

DENG Xiaoqin

ZHAO Chi

LI Zhaohong

YAN Hongyan

SHEN Dongfang

TAN Helang

JIANG Mingzhong

DENG Nanjun

Related Institution

Dept. of Pharmacy， Zhongxian People’s Hospital of Chongqing， Chongqing Zhongxian

Psychic Health Research Institute， the Second Xiangya Hospital of Central South University

Shanghai Mental Health Center Affiliated to Shanghai Jiao Tong University School of Medicine/National Center for Mental Disorder

Peking University Sixth Hospital/National Clinical Research Center for Psychiatric and Mental Disorders

Dept. of Hematology， the First Hosptial of Hebei Medical University

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰